Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. NHI
stocks logo

NHI

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
94.84M
+10.6%
0.806
-15.16%
91.49M
+2.45%
0.815
+10.14%
93.83M
+3.49%
0.856
+8.34%
Estimates Revision
The market is revising Upward the revenue expectations for National Health Investors, Inc. (NHI) for FY2025, with the revenue forecasts being adjusted by 1.41% over the past three months. During the same period, the stock price has changed by 0.82%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.41%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+1.27%
In Past 3 Month
Stock Price
Go Up
up Image
+0.82%
In Past 3 Month
Wall Street analysts forecast NHI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NHI is 87.50 USD with a low forecast of 80.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast NHI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NHI is 87.50 USD with a low forecast of 80.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 79.040
sliders
Low
80.00
Averages
87.50
High
90.00
Current: 79.040
sliders
Low
80.00
Averages
87.50
High
90.00
KeyBanc
Overweight
maintain
$80 -> $88
2025-12-04
New
Reason
KeyBanc
Price Target
$80 -> $88
2025-12-04
New
maintain
Overweight
Reason
KeyBanc raised the firm's price target on National Health Investors to $88 from $80 and keeps an Overweight rating on the shares. The firm views National Health Investors as an attractive way to gain exposure to a Healthcare REIT with an attractive cost of capital and below average leverage that can capitalize on the current investment landscape and drive upside to 2026 and 2027 NFFO estimates. Importantly, the investments should continue to grow the company's Senior Housing Operating Portfolio exposure and potentially enhance its internal growth profile, over time. Moreover, potential positive catalysts from available market rent resets and lease expirations in early-to-mid 2026 could drive additional upside to NFFO estimates, KeyBanc adds.
Wells Fargo
John Kilichowski
Equal Weight
maintain
$80 -> $85
2025-11-25
Reason
Wells Fargo
John Kilichowski
Price Target
$80 -> $85
2025-11-25
maintain
Equal Weight
Reason
Wells Fargo analyst John Kilichowski raised the firm's price target on National Health Investors to $85 from $80 and keeps an Equal Weight rating on the shares. The firm says that despite a few high-profile exceptions, most REITs delivered Q3 2025 earnings and outlooks reflecting healthy operating conditions despite macro and labor market concerns.
BofA
Buy
maintain
$88 -> $90
2025-11-17
Reason
BofA
Price Target
$88 -> $90
2025-11-17
maintain
Buy
Reason
BofA raised the firm's price target on National Health Investors to $90 from $88 and keeps a Buy rating on the shares. While stock performance did not reflect it, Q3 earnings season was "strong" for U.S. REITs as 69% of REITs beat the Street, the analyst tells investors in a note on the group.
BofA
Buy
maintain
$87 -> $88
2025-10-17
Reason
BofA
Price Target
$87 -> $88
2025-10-17
maintain
Buy
Reason
BofA raised the firm's price target on National Health Investors (NHI) to $88 from $87 and keeps a Buy rating on the shares. A "silver tsunami' in the U.S. is expected to to drive big gains for the major players in the senior housing business as Boomers age into senior living, says the analyst, who forecasts that margins for the five SHOP REITs- Welltower (WELL), Ventas (VTR), Sabra (SBRA), American Healthcare REIT (AHR) and National Health - will expand ahead of Street estimates in 2026.
Cantor Fitzgerald
Overweight
initiated
$90
2025-10-01
Reason
Cantor Fitzgerald
Price Target
$90
2025-10-01
initiated
Overweight
Reason
Cantor Fitzgerald initiated coverage of National Health Investors with an Overweight rating and $90 price target. The firm initiated coverage of the U.S. REITs, including nine property sectors and 40 stocks. Although there isn't widespread enthusiasm for a REIT recovery in 2026 just yet, Cantor believes the industry could be well-positioned over the next 12 to 24 months, the analyst tells investors in a research note. The firm's top property sector calls include Office, Industrial, Healthcare and Net Lease, but is incrementally more cautious on Multifamily and Hotels.
Truist
Buy
maintain
$77 -> $81
2025-08-15
Reason
Truist
Price Target
$77 -> $81
2025-08-15
maintain
Buy
Reason
Truist raised the firm's price target on National Health Investors to $81 from $77 and keeps a Buy rating on the shares. The firm cites the company's Q2 earnings beat and raise, along with the encouraging outlook from its management, the analyst tells investors in a research note. Truist is projecting healthy earnings growth, supported by the 2026-end rent reset for National Healthcare Corporation and an attractive investment yield spread over the company's cost of capital.
See All Ratings

Valuation Metrics

The current forward P/E ratio for National Health Investors Inc (NHI.N) is 23.72, compared to its 5-year average forward P/E of 20.99. For a more detailed relative valuation and DCF analysis to assess National Health Investors Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
20.99
Current PE
23.72
Overvalued PE
24.07
Undervalued PE
17.90

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
15.30
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
16.63
Undervalued EV/EBITDA
13.97

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
8.90
Current PS
0.00
Overvalued PS
10.12
Undervalued PS
7.68
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

NHI News & Events

Events Timeline

(ET)
2025-08-06
17:50:42
National Health Investors reports Q2 EPS 79c, consensus 75c
select
2025-05-13 (ET)
2025-05-13
17:10:00
National Health Investors issues statement in response to ISS recommendation
select
2025-05-12 (ET)
2025-05-12
11:15:39
Land & Buildings says ISS recommends NHI stockholders vote for director nominees
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
11-22NASDAQ.COM
National Health Investors (NHI) Pursues Acquisition: Reasons for the Upgrade

  • Zacks Rank Upgrade: National Health Investors (NHI) has been upgraded to a Zacks Rank #2 (Buy), indicating a positive earnings outlook that could lead to an increase in stock price.

  • Earnings Estimate Revisions: The Zacks Consensus Estimate for NHI has risen by 1.9% over the past three months, reflecting analysts' growing confidence in the company's earnings potential.

  • Investment Strategy: The Zacks Rank system, which categorizes stocks based on earnings estimate revisions, has a strong track record, with top-rated stocks historically generating significant returns.

  • Market Positioning: NHI's upgrade places it in the top 20% of Zacks-covered stocks, suggesting it is well-positioned for potential market-beating returns in the near term.

[object Object]
Preview
6.5
10-21CNBC
The S&P 500 Becomes an AI-Focused Index: Stocks to Diversify Your Portfolio Against Potential Setbacks

  • Investor Caution on AI Stocks: With high valuations in AI stocks, investors are advised to diversify their portfolios, as the S&P 500 is heavily influenced by tech and AI-related companies. Trivariate Research's Adam Parker suggests that the current market conditions resemble a "rational bubble," with potential risks for investors.

  • Stock Performance and Recommendations: Parker recommends looking for stocks with low correlation to AI semiconductors that have shown at least a 10% increase over the last six months, are of high quality, and have lower volatility. Notable companies like Walmart and Netflix are highlighted for their performance and strategic use of AI, while Welltower is expected to benefit from the aging population in the senior housing sector.

[object Object]
Preview
2.0
10-14NASDAQ.COM
National Health Investors (NHI) Stock Falls Below 200-Day Moving Average

  • NHI Stock Performance: NHI's stock has a 52-week low of $65.13 and a high of $82.32, with the last trade recorded at $72.22.

  • Dividend Stocks Update: The article mentions that there are 9 other dividend stocks that have recently fallen below their 200-day moving average.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is National Health Investors Inc (NHI) stock price today?

The current price of NHI is 79.04 USD — it has increased 0.24 % in the last trading day.

arrow icon

What is National Health Investors Inc (NHI)'s business?

National Health Investors, Inc. is a real estate investment trust. The Company specializes in sales, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment consists of real estate investments, leases, and mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has approximately 193 healthcare real estate properties located in 33 states and leased primarily pursuant to triple-net leases to 27 tenants. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. This segment has over 15 properties located in eight states with a combined 1,732 units.

arrow icon

What is the price predicton of NHI Stock?

Wall Street analysts forecast NHI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NHI is 87.50 USD with a low forecast of 80.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is National Health Investors Inc (NHI)'s revenue for the last quarter?

National Health Investors Inc revenue for the last quarter amounts to 89.85M USD, increased 8.32 % YoY.

arrow icon

What is National Health Investors Inc (NHI)'s earnings per share (EPS) for the last quarter?

National Health Investors Inc. EPS for the last quarter amounts to 0.69 USD, increased 6.15 % YoY.

arrow icon

What changes have occurred in the market's expectations for National Health Investors Inc (NHI)'s fundamentals?

The market is revising Upward the revenue expectations for National Health Investors, Inc. (NHI) for FY2025, with the revenue forecasts being adjusted by 1.41% over the past three months. During the same period, the stock price has changed by 0.82%.
arrow icon

How many employees does National Health Investors Inc (NHI). have?

National Health Investors Inc (NHI) has 25 emplpoyees as of December 05 2025.

arrow icon

What is National Health Investors Inc (NHI) market cap?

Today NHI has the market capitalization of 3.76B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free